Companies Cryptocurrencies
Iterum Therapeutics PLC
Iterum Therapeutics PLC
Exchange: NasdaqGM
IPO Date: 25/05/2018
CEO: Mr. Corey Fishman
Biotechnology Healthcare 🔗
  • ITRM
  • 0.2395
  • 43913040
    market cap
  • 0.021
If you bought

shares of Iterum Therapeutics PLC (ITRM) on
You would have made
Old Price $12 Current Price $12

Iterum Therapeutics Plc is a pharmaceutical company which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company is headquartered in Dublin, Dublin and currently employs 48 full-time employees. The firm is focused on developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens. The firm is developing sulopenem – the oral and intervenous (IV) penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative. The company is a bioavailable, antibiotic covering gram-positive, gram-negative and anaerobic pathogen with in-vitro activity against multidrug-resistant pathogens, including Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia, coli and Klebsiella and pneumonia. The company has demonstrated potent in vitro activity against all genera of Enterobacteriacease, in anaerobes such as Bacteroides, Prevotella, Porphyromonas, Fusobacterium and Peptostreptococcus, gram-positive organisms including methicillin-susceptible staphylococci, Streptococcus pyogenes and Streptococcus pneumonia.

Address: Block 2 Floor 3 Harcourt Centre Harcourt Street DUBLIN DUBLIN 2

Stay updated.